Rai KR - Search Results

1

Developmental subtypes assessed by DNA methylation-iPLEX forecast the natural history of chronic lymphocytic leukemia.

Giacopelli B, Zhao Q, Ruppert AS, Agyeman A, Weigel C, Wu YZ, Gerber MM, Rabe KG, Larson MC, Lu J, Blachly JS, Rogers KA, Wierda WG, Brown JR, Rai KR, Keating M, Rassenti LZ, Kipps TJ, Zenz T, Shanafelt TD, Kay NE, Abruzzo LV, Coombes KR, Woyach JA, Byrd JC, Oakes CC. Giacopelli B, et al. Among authors: rai kr. Blood. 2019 Aug 22;134(8):688-698. doi: 10.1182/blood.2019000490. Epub 2019 Jul 10. Blood. 2019. PMID: 31292113 Free PMC article.

2

Response criteria with fludarabine therapy in chronic lymphocytic leukemia.

Rai KR. Rai KR. Blood. 1994 Feb 1;83(3):875-6. Blood. 1994. PMID: 8298148 Free article. No abstract available.

3

Mutator phenotype in a subset of chronic lymphocytic leukemia.

Gartenhaus R, Johns MM 3rd, Wang P, Rai K, Sidransky D. Gartenhaus R, et al. Blood. 1996 Jan 1;87(1):38-41. Blood. 1996. PMID: 8547666 Free article.

4

Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with In vitro and In vivo chemoresponses.

Kitada S, Andersen J, Akar S, Zapata JM, Takayama S, Krajewski S, Wang HG, Zhang X, Bullrich F, Croce CM, Rai K, Hines J, Reed JC. Kitada S, et al. Blood. 1998 May 1;91(9):3379-89. Blood. 1998. PMID: 9558396 Free article.

5

Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study.

Keating MJ, Flinn I, Jain V, Binet JL, Hillmen P, Byrd J, Albitar M, Brettman L, Santabarbara P, Wacker B, Rai KR. Keating MJ, et al. Among authors: rai kr. Blood. 2002 May 15;99(10):3554-61. doi: 10.1182/blood.v99.10.3554. Blood. 2002. PMID: 11986207 Free article. Clinical Trial.

6

Biology and treatment of chronic lymphocytic leukemia.

Keating MJ, Chiorazzi N, Messmer B, Damle RN, Allen SL, Rai KR, Ferrarini M, Kipps TJ. Keating MJ, et al. Among authors: rai kr. Hematology Am Soc Hematol Educ Program. 2003:153-75. doi: 10.1182/asheducation-2003.1.153. Hematology Am Soc Hematol Educ Program. 2003. PMID: 14633781 Review.

7

ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia.

Rassenti LZ, Huynh L, Toy TL, Chen L, Keating MJ, Gribben JG, Neuberg DS, Flinn IW, Rai KR, Byrd JC, Kay NE, Greaves A, Weiss A, Kipps TJ. Rassenti LZ, et al. Among authors: rai kr. N Engl J Med. 2004 Aug 26;351(9):893-901. doi: 10.1056/NEJMoa040857. N Engl J Med. 2004. PMID: 15329427 Free article.

8

Evolution of treatment strategies in chronic lymphocytic leukemia. Part 2 of a 3-Part series: Advances in the treatment of hematologic malignancies.

Keating MJ, Rai KR, Wierda WG. Keating MJ, et al. Among authors: rai kr. Clin Adv Hematol Oncol. 2005 Aug;3(8):1-10; quiz 11-2. Clin Adv Hematol Oncol. 2005. PMID: 16201050

9

Chronic lymphocytic leukemia: current and emerging treatment approaches.

Kay NE, Rai KR, O'Brien S. Kay NE, et al. Among authors: rai kr. Clin Adv Hematol Oncol. 2006 Nov;4(11 Suppl 22):1-10; quiz 11-2. Clin Adv Hematol Oncol. 2006. PMID: 17143256 Review.

10

Nonstochastic pairing of immunoglobulin heavy and light chains expressed by chronic lymphocytic leukemia B cells is predicated on the heavy chain CDR3.

Widhopf GF 2nd, Goldberg CJ, Toy TL, Rassenti LZ, Wierda WG, Byrd JC, Keating MJ, Gribben JG, Rai KR, Kipps TJ. Widhopf GF 2nd, et al. Among authors: rai kr. Blood. 2008 Mar 15;111(6):3137-44. doi: 10.1182/blood-2007-02-073130. Epub 2007 Aug 3. Blood. 2008. PMID: 17675554 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

226 results

Search Page

Filters